All three of the challenges that the Patent Trial and Appeal Board (PTAB) instituted in 2022 resulted in a final written decision canceling the challenged patent. Two of the three final.
Statutory disclaimers to avoid institution at the Patent Trial and Appeal Board should be used cautiously, warn Jon Carter and W Todd Baker of Kirkland & Ellis.